Efficacy and safety of therapeutic alpha-1-microglobulin RMC-035 in reducing kidney injury after cardiac surgery: a multicentre, randomised, double-blind, parallel group, phase 2a trial.

  • Publikationsjahr: 2024
  • Titel: Efficacy and safety of therapeutic alpha-1-microglobulin RMC-035 in reducing kidney injury after cardiac surgery: a multicentre, randomised, double-blind, parallel group, phase 2a trial.
  • Autoren: Zarbock A, Larsson TE, Noiseux N, Mazer CD, Böhm J, Laflamme M, Matschke K, Burkert J, de Varennes B, Myjavec A, Böning A, Koyner JL, Engelman D, Reusch M, Thielmann M
  • Journal: EClinicalMedicine
  • DOI: 10.1016/j.eclinm.2024.102830
  • DGAI-Beteiligte: Zarbock A: Universitätsklinikum Münster